University of Haifa
Haifa, Israel
NCT Number: NCT03709615
The current study examines therapeutic processes during internet-based cognitive-behavioral therapy for social anxiety disorder. Participants will be randomized to either treatment or wait-list conditions. Participants in the wait-list condition will receive active treatment following the wait-list period.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Not applicable
Haifa, Israel
Internet-based cognitive-behavioral therapy (iCBT) is an effective treatment for social anxiety disorder (SAD). However, little is known about the processes and mechanisms of change in this treatment. Compared to face to face (FTF) treatments, online interventions may operate through partially different mechanisms of change due to the text-based nature of the interaction and the reduced level of therapist involvement. The present randomized controlled trial will examine therapeutic processes during iCBT for SAD including the presence of sudden gains and their relationship to outcome, the relationship between anxiety and depressive symptoms along the course of treatment, changes in the therapeutic alliance and attrition from therapy. Moreover, we will compare iCBT for SAD with a wait-list control group and utilize weekly measurements of anxiety, depression, and SAD-related cognitions in both groups. This will facilitate comparison between temporal processes in both conditions and also shed light on processes occurring in wait-list conditions.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
An internet-based CBT for social anxiety based on a protocol from Andersson et al., 2006:
"Internet-based self-help with therapist feedback and in vivo group exposure for social phobia: a randomized controlled trial."
Time frame: Change from Baseline LSAS at post treatment (12 weeks)
Post treatment Liebowitz Social Anxiety Scale (LSAS). Score ranges from 0 to 144 where higher score indicates more sever social anxiety
Time frame: Change from Baseline ADIS diagnosis at post treatment (12 weeks)
Diagnoses derived from the Anxiety and Related Disorders Interview Schedule for DSM-5 (ADIS)
Time frame: Change from Baseline LSAS at 6 months follow-up
Follow-up Liebowitz Social Anxiety Scale (LSAS). Score ranges from 0 to 144 where higher score indicates more sever social anxiety
Time frame: Change from Baseline SPIN at post treatment (12 weeks)
Post treatment Social Phobia Inventory (SPIN). Score ranges from 0 to 68 where higher score indicates more sever social anxiety
Time frame: Change from Baseline SPIN at 6 months follow-up
Post treatment Social Phobia Inventory (SPIN). Score ranges from 0 to 68 where higher score indicates more sever social anxiety
Time frame: Change from Baseline BDI-II at post treatment (12 weeks)
Post treatment Beck Depression Inventory II, (BDI-II). Score ranges from 0 to 63 where higher score indicates more sever depression.
Time frame: Change from Baseline BDI-II at 6 months follow-up
Post treatment Beck Depression Inventory II, (BDI-II). Score ranges from 0 to 63 where higher score indicates more sever depression.
University of Haifa
Other
Therapeutic Processes in Internet-Based CBT for Social Anxiety Disorder: A Randomized Controlled Trial.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02810171
Agoraphobia, Anxiety
Ann Arbor, Michigan, United States
View Trial DetailsNCT03514225
Anxiety Disorders, Mental Disorders
Manchester, Greater Manchester, United Kingdom
View Trial DetailsNCT00246441
Alcohol Abuse, Alcohol Dependence
Charleston, South Carolina, United States
View Trial DetailsNCT01746667
Anxiety Disorders, Mental Disorders
Amsterdam, Netherlands
View Trial Details